Selected research
Industry Research
Runing Capsules Industry Research Report 2026
Market perspective
The global Runing Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Runing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Runing Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Runing Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Runing Capsules include Xi'an Renren Pharmaceutical Co., Ltd., Xi'an Qianhe Pharmaceutical Co., Ltd., Shaanxi Junbisa Pharmaceutical Co., Ltd., Shaanxi Dongtai Pharmaceutical Co., Ltd., Longyao Huangfumi Pharmaceutical Co., Ltd., Jilin Aodong Yanbian Pharmaceutical Co., Ltd., Heilongjiang Tianyi Pharmaceutical Co., Ltd., Henan Runhong Pharmaceutical Co., Ltd. and Guangxi Gufang Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Runing Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Runing Capsules Market by Company
Xi'an Renren Pharmaceutical Co., Ltd.
Xi'an Qianhe Pharmaceutical Co., Ltd.
Shaanxi Junbisa Pharmaceutical Co., Ltd.
Shaanxi Dongtai Pharmaceutical Co., Ltd.
Longyao Huangfumi Pharmaceutical Co., Ltd.
Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
Heilongjiang Tianyi Pharmaceutical Co., Ltd.
Henan Runhong Pharmaceutical Co., Ltd.
Guangxi Gufang Pharmaceutical Co., Ltd.
Anhui Baichun Pharmaceutical Co., Ltd.
Runing Capsules Segment by Type
Bottled
Boxed
Runing Capsules Segment by Application
Hospital
Clinic
Other
Runing Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Runing Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Runing Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Runing Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Runing Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Runing Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Runing Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bottled
- Boxed
Applications
- Hospital
- Clinic
- Other
Companies covered
- Xi'an Renren Pharmaceutical Co., Ltd.
- Xi'an Qianhe Pharmaceutical Co., Ltd.
- Shaanxi Junbisa Pharmaceutical Co., Ltd.
- Shaanxi Dongtai Pharmaceutical Co., Ltd.
- Longyao Huangfumi Pharmaceutical Co., Ltd.
- Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
- Heilongjiang Tianyi Pharmaceutical Co., Ltd.
- Henan Runhong Pharmaceutical Co., Ltd.
- Guangxi Gufang Pharmaceutical Co., Ltd.
- Anhui Baichun Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Runing Capsules Market Size (2021-2032)
- 2.2.2 Global Runing Capsules Sales (2021-2032)
- 2.2.3 Global Runing Capsules Market Average Price (2021-2032)
- 2.3 Runing Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bottled
- 2.3.3 Boxed
- 2.4 Runing Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Runing Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Runing Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Runing Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Runing Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Runing Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Runing Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Runing Capsules, Product Type & Application
- 3.8 Global Manufacturers of Runing Capsules, Established Date
- 3.9 Global Runing Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Xi'an Renren Pharmaceutical Co., Ltd.
- 4.1.1 Xi'an Renren Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Xi'an Renren Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Xi'an Renren Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Xi'an Renren Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.1.5 Xi'an Renren Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Xi'an Qianhe Pharmaceutical Co., Ltd.
- 4.2.1 Xi'an Qianhe Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Xi'an Qianhe Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Xi'an Qianhe Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xi'an Qianhe Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.2.5 Xi'an Qianhe Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Shaanxi Junbisa Pharmaceutical Co., Ltd.
- 4.3.1 Shaanxi Junbisa Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Shaanxi Junbisa Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Shaanxi Junbisa Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shaanxi Junbisa Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.3.5 Shaanxi Junbisa Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Shaanxi Dongtai Pharmaceutical Co., Ltd.
- 4.4.1 Shaanxi Dongtai Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Shaanxi Dongtai Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Shaanxi Dongtai Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shaanxi Dongtai Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.4.5 Shaanxi Dongtai Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Longyao Huangfumi Pharmaceutical Co., Ltd.
- 4.5.1 Longyao Huangfumi Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Longyao Huangfumi Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Longyao Huangfumi Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Longyao Huangfumi Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.5.5 Longyao Huangfumi Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
- 4.6.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.6.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Heilongjiang Tianyi Pharmaceutical Co., Ltd.
- 4.7.1 Heilongjiang Tianyi Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Heilongjiang Tianyi Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Heilongjiang Tianyi Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Heilongjiang Tianyi Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.7.5 Heilongjiang Tianyi Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Henan Runhong Pharmaceutical Co., Ltd.
- 4.8.1 Henan Runhong Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Henan Runhong Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Henan Runhong Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Henan Runhong Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.8.5 Henan Runhong Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Guangxi Gufang Pharmaceutical Co., Ltd.
- 4.9.1 Guangxi Gufang Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Guangxi Gufang Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Guangxi Gufang Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Guangxi Gufang Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.9.5 Guangxi Gufang Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Anhui Baichun Pharmaceutical Co., Ltd.
- 4.10.1 Anhui Baichun Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Anhui Baichun Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Anhui Baichun Pharmaceutical Co., Ltd. Runing Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Anhui Baichun Pharmaceutical Co., Ltd. Runing Capsules Product Portfolio
- 4.10.5 Anhui Baichun Pharmaceutical Co., Ltd. Recent Developments
5 Global Runing Capsules Market Scenario by Region
- 5.1 Global Runing Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Runing Capsules Sales by Region: 2021-2032
- 5.2.1 Global Runing Capsules Sales by Region: 2021-2026
- 5.2.2 Global Runing Capsules Sales by Region: 2027-2032
- 5.3 Global Runing Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Runing Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Runing Capsules Revenue by Region: 2027-2032
- 5.4 North America Runing Capsules Market Facts & Figures by Country
- 5.4.1 North America Runing Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Runing Capsules Sales by Country (2021-2032)
- 5.4.3 North America Runing Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Runing Capsules Market Facts & Figures by Country
- 5.5.1 Europe Runing Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Runing Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Runing Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Runing Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Runing Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Runing Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Runing Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Runing Capsules Market Facts & Figures by Country
- 5.7.1 South America Runing Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Runing Capsules Sales by Country (2021-2032)
- 5.7.3 South America Runing Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Runing Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Runing Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Runing Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Runing Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Runing Capsules Sales by Type (2021-2032)
- 6.1.1 Global Runing Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Runing Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Runing Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Runing Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Runing Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Runing Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Runing Capsules Sales by Application (2021-2032)
- 7.1.1 Global Runing Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Runing Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Runing Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Runing Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Runing Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Runing Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Runing Capsules Value Chain Analysis
- 8.1.1 Runing Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Runing Capsules Production Mode & Process
- 8.2 Runing Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Runing Capsules Distributors
- 8.2.3 Runing Capsules Customers
9 Global Runing Capsules Analyzing Market Dynamics
- 9.1 Runing Capsules Industry Trends
- 9.2 Runing Capsules Industry Drivers
- 9.3 Runing Capsules Industry Opportunities and Challenges
- 9.4 Runing Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst